Construction, Expression and Immunogenicity Analysis of a Tat N-terminusdeleted Mutant Fusion Protein of Human Immunodeficiency Virus Type 1

Hua-Qun Zhang,Wen-Ting Liao,Qiu-Li Chen,Yi-Bing Ge,Jie Yang,Ping-Ping Zhang,Pei-Pei Qi,Chao Liu,Ting He,Jin-Hong Wang,Wei Pan,Jie Cao
DOI: https://doi.org/10.13242/j.cnki.bingduxuebao.002225
2011-01-01
Abstract:In the study, a gene encoding Tat protein N terminal 1- 21 amino acid residues-deleted mutant (Tat22-101) was amplified by PCR from a full length Tat gene of human immunodeficiency virus type 1, and the prokaryotic expression plasmid pET32a-Tat22-101 was constructed. After identification by digestion with endonucleases and sequencing, the recombinant plasmid pET32a-Tat22-101 was transformed into E. coli BL21(DE3) and expressed with IPTG induction. The mutant fusion protein with deleted Tat N terminal was purified by an affinity chromatography column Ni(2+)-NTA and subsequently identified by SDS-PAGE and Western blotting. The results showed that the molecular weight of the mutant protein was approximately 26.9kD. Furthermore, BALB/c mice were immunized with the mutant protein and the anti-sera were collected. ELISA results showed that the mutant protein preserved its immunogenicity, particularly it could improve the production of antibodies to other epitopes in addition to the N terminal epitope of Tat protein, which might provide some valuable information for the study of Tat functions as well as for development of potential novel HIV Tat vaccine.
What problem does this paper attempt to address?